Literature DB >> 15623430

NHE-1 inhibition improves impaired mitochondrial permeability transition and respiratory function during postinfarction remodelling in the rat.

Sabzali Javadov1, Cathy Huang, Lorrie Kirshenbaum, Morris Karmazyn.   

Abstract

The mechanism by which Na+-H+ exchange (NHE) inhibition results in attenuation and reversal of postinfarction remodelling and heart failure remains controversial. In this study, we investigated the possible contribution of mitochondrial involvement by determining the effect of the NHE-1-specific inhibitor EMD-87580 (EMD) on mitochondrial permeability transition (MPT) and respiratory function during the postinfarction remodelling process. Male Sprague-Dawley rats were subjected to either 12 or 18 weeks of coronary artery ligation (CAL) or sham procedure. EMD was provided in the diet immediately after ligation. MPT pore opening was determined by perfusing hearts with 2-deoxy-[3H]-glucose ([3H]-DOG) and measurement of mitochondrial [3H]-DOG entrapment. The respiratory function of isolated mitochondria was measured using Clark-type oxygen electrode. Remodelling was associated with significant hypertrophy and there was an increase in MPT pore opening in hearts both 12 and 18 weeks following CAL. Mitochondrial respiratory function, especially state 2 and state 3 rates were significantly decreased in hearts subjected to CAL. EMD suppressed MPT pore opening by 40% (P <0.01) and 35% (P <0.01) 12 and 18 weeks after ligation, respectively. Mitochondria isolated from EMD treated hearts exhibited increased respiratory chain activity for oxidation of substrates at complex I and II. These beneficial effects of EMD were associated with decreased mitochondrial vulnerability to exogenous Ca2+. We conclude that NHE-1 inhibition has a protective effect on mitochondrial function, attenuating MPT pore opening and improving the respiratory function, which may contribute to the salutary effect of NHE-1 inhibitors in heart failure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15623430     DOI: 10.1016/j.yjmcc.2004.10.007

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  17 in total

1.  In vivo opening of the mitochondrial permeability transition pore in a rat model of ventricular fibrillation and closed-chest resuscitation.

Authors:  Iyad M Ayoub; Jeejabai Radhakrishnan; Raúl J Gazmuri
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

2.  Docosahexaenoic acid supplementation alters key properties of cardiac mitochondria and modestly attenuates development of left ventricular dysfunction in pressure overload-induced heart failure.

Authors:  Erinne R Dabkowski; Kelly A O'Connell; Wenhong Xu; Rogerio F Ribeiro; Peter A Hecker; Kadambari Chandra Shekar; Caroline Daneault; Christine Des Rosiers; William C Stanley
Journal:  Cardiovasc Drugs Ther       Date:  2013-12       Impact factor: 3.727

3.  Letter to the editor: "cyclosporin A in left ventricular remodeling after myocardial infarction".

Authors:  Sabzali Javadov
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-01       Impact factor: 4.733

4.  Excessive Na+/H+ exchange in disruption of dendritic Na+ and Ca2+ homeostasis and mitochondrial dysfunction following in vitro ischemia.

Authors:  Douglas B Kintner; Xinzhi Chen; Julia Currie; Vishal Chanana; Peter Ferrazzano; Akemichi Baba; Toshio Matsuda; Mike Cohen; John Orlowski; Shing-Yan Chiu; Jack Taunton; Dandan Sun
Journal:  J Biol Chem       Date:  2010-09-03       Impact factor: 5.157

5.  Direct renin inhibition exerts an anti-hypertrophic effect associated with improved mitochondrial function in post-infarction heart failure in diabetic rats.

Authors:  Rebecca Parodi-Rullan; Giselle Barreto-Torres; Louis Ruiz; José Casasnovas; Sabzali Javadov
Journal:  Cell Physiol Biochem       Date:  2012-05-11

6.  High intake of saturated fat, but not polyunsaturated fat, improves survival in heart failure despite persistent mitochondrial defects.

Authors:  Tatiana F Galvao; Bethany H Brown; Peter A Hecker; Kelly A O'Connell; Karen M O'Shea; Hani N Sabbah; Sharad Rastogi; Caroline Daneault; Christine Des Rosiers; William C Stanley
Journal:  Cardiovasc Res       Date:  2011-09-29       Impact factor: 10.787

Review 7.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

Review 8.  Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.

Authors:  Yan Burelle; Maya Khairallah; Alexis Ascah; Bruce G Allen; Christian F Deschepper; Basil J Petrof; Christine Des Rosiers
Journal:  J Mol Cell Cardiol       Date:  2009-09-18       Impact factor: 5.000

9.  Dietary omega-3 fatty acids alter cardiac mitochondrial phospholipid composition and delay Ca2+-induced permeability transition.

Authors:  Karen M O'Shea; Ramzi J Khairallah; Genevieve C Sparagna; Wenhong Xu; Peter A Hecker; Isabelle Robillard-Frayne; Christine Des Rosiers; Tibor Kristian; Robert C Murphy; Gary Fiskum; William C Stanley
Journal:  J Mol Cell Cardiol       Date:  2009-08-22       Impact factor: 5.000

10.  Marine n3 polyunsaturated fatty acids enhance resistance to mitochondrial permeability transition in heart failure but do not improve survival.

Authors:  Tatiana F Galvao; Ramzi J Khairallah; Erinne R Dabkowski; Bethany H Brown; Peter A Hecker; Kelly A O'Connell; Karen M O'Shea; Hani N Sabbah; Sharad Rastogi; Caroline Daneault; Christine Des Rosiers; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-10-26       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.